Comparison of efficacy and safety of topical glyceryl trinitrate vs. oral nifedipine in idiopathic perniosis: results of a randomized clinical trial
Keywords:
Perniosis, chilblains, nifedipine, glyceryl trinitrateAbstract
Objective To compare the therapeutic efficacy and safety of topical vasodilator glyceryl trinitrate (GTN) 0.4% cream, with systemic nifedipine (10-40mg/day) in patients with idiopathic perniosis (IP). Methods Patients with IP (n=65) were randomized into group A receiving GTN 0.4% cream (n=31) or group B receiving oral nifedipine, 10-40mg/day (n=34). They were evaluated for improvement in signs and symptoms and any side effects, every 15 days for six weeks. Primary outcome was efficacy and secondary outcome was side effects.  Results 53 patients completed the study protocol. Twenty-three out of 26 (88%) patients in group A whereas 21 out of 27 (77%) in group B had complete clearance of lesions in six weeks (p=0.52). Clearance of lesions was achieved earlier (10.9 ±6 days) in group B as compared to (16.6±11.5 days) group A (p=0.05). Conclusion GTN 0.4% cream is an effective and safe alternative to oral nifedipine in the treatment of IP. Oral nifedipine leads to clearance of lesions earlier than GTN cream.ÂReferences
Creamer D. Reactions to cold. In: Burns T, Breathnach S, Cox N, Griffiths C, editor. Rook’s Textbook of Dermatology, 8th edn. Oxford: Wiley-Blackwell Scientific Publication; 2010. p. 28.63-28.74.
Pierard GE, Henry F, Franchimont CP. Cold injuries. In: Wolff K, Goldsmith LA, Katz SI et al., eds. Fitzpatrick’s Dermatology in General Medicine 7th edn, Vol 1. New York: McGraw-Hill; 2008. p.844-51
Larkins N, Murray KJ. Major cluster of chilblain cases in a cold dry Western Australian winter. J Paediatr Child Health. 2013;49:144-7.
Hallam R. The enigma of the chilblain. Br Med J. 1931;1(3657): 215-16.
Cappaert TA, Stone JA, Krause BA et al. National Athletic Trainers’ Association Position Statement: Environmental cold Injuries. J Athl Train. 2008;43:640-58.
Oumeish O. Common acrally distributed dermatoses. Clin Dermatol. 2011;29:130-9.
Boada A, Bielsa I, Ferna´ndez-Figueras MT, Ferra´ndiz C. Perniosis: clinical and histopathological analysis. Am J Dermatopathol. 2010;32:19-23.
Chan Y LW, Li SPS, Tang WYM et al. A cluster of chilblains in Hong Kong. Hong Kong Med J. 2008;14:185-91.
Jordaan H. The diagnosis and management of perniosis (chilblains). SA Fam Pract. 2007;49:28-9.
Rustin MH, Newton JA, Smith NP, Dowd PM. The treatment of chilblains with nifedipine: the results of a pilot study, a double blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol. 1989;120:267-75.
Anderson ME, Moore TL, Hollis S et al. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology. 2002;41:324-8.
World Climate Guide. Retrieved from: URL http:// www.worldclimateguide.co.uk. Accessed on Jan 11, 2014.
Raza N, Habib A, Razvi SA, Dar NR. Constitutional and behavioral risk factors for chilblains: A case-control study from Pakistan. Wilderness Environ Med. 2010;21:17-21
Raza N, Sajid MD, Suhail M, Rashid H. Onset of chilblains in relation with weather conditions. J Ayyub Med Coll Abbottabad. 2008;20:17-20.
Pramanik T, Jha AK, Ghimire A. A retrospective study of cases presenting with chilblains (Perniosis) in Out-patient Department Of Dermatology, Nepal Medical College and Teaching Hospital (NMCTH). Nepal Med Coll J. 2011;13:190-2.
Singh GK, Chatterjee M, Grewal RS, Verma R. Incidence and care of environmental dermatoses in the high-altitude region of Ladakh, India. Indian J Dermatol. 2013;58:107-12.
Takci Z, Vahaboglu G, Eksioglu H. Epidemiological patterns of perniosis, and its association with systemic disorder. Clin Exp Dermatol. 2012;37:844-9
Simon TD, Soep JB, Hollister RJ. Pernio in Pediatrics. Pediatrics. 2005;116:e472-e5.
Dowd PM, Rustin MH, Lenigan S. Nifedipine in the treatment of chilblains. Br Med J. 1986;293:923-4.
Patra AK, Das AL, Ramadasan P. Diltiazem vs. nifedipine in chilblains: A clinical trial. Indian J Dermatol Venereol Leprol. 2003;69:209-11.
McMahan ZH, Wigley FM. Raynaud’s phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management. Int J Clin Rheumatol. 2010;5:355-70.
Haywood A, Glass B. Nifedipine for the treatment of chilblains. Pharmacist. 2011;30:664-7.
Brochure-DRDO. Available from: http://www.drdo.gov.in/drdo/labs/INMAS/collaboration/brochure.htm
